SYP and Patent ductus arteriosus: We also analyzed circulating tumor cells (CTCs) from patients with PDA for neuroendocrine marker expression and found co-staining of CK and SYP (Fig. 1e) in 4 of 5 patients assessed with a frequency ranging from 30 to 66% (Fig. 1f).